SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS

12 Months Ended

Dec. 31, 2024

SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]

SCHEDULE II VALUATION AND QUALIFYING ACCOUNTS

SCHEDULE II

VALUATION AND QUALIFYING ACCOUNTS

Allowance for Doubtful Accounts


(In thousands)
Description	Balance at Beginning of Period		Charges to Costs, Expenses and Other		Write-off of Accounts Receivable		Other (1)		Balance at End of Period
Year ended December 31, 2022	$	29,270	$	14,236	$	(14,322)	$	(13)	$	29,171
Year ended December 31, 2023	29,171		29,488		(20,613)		9		38,055
Year ended December 31, 2024	38,055		15,888		(17,374)		(17)		36,552

(1)Primarily foreign currency adjustments and acquisition and/or divestiture activity.

Deferred Tax Asset Valuation Allowance


(In thousands)
Description	Balance at Beginning of Period		Charges to Costs, Expenses and Other (1)		Reversal (2)		Adjustments(3)		Balance at End of Period
Year ended December 31, 2022	$	1,854,143	$	49,234	$	(4,209)	$	2,023	$	1,901,191
Year ended December 31, 2023	1,901,191		114,061		(59,249)		230		1,956,233
Year ended December 31, 2024	1,956,233		195,625		(226,617)		(1,433,017)		492,224

(1)During 2024, 2023, and 2022 the Company recorded a valuation allowance of $195.6 million, $114.1 million and $49.2 million, respectively, on a portion of its deferred tax assets attributable to federal and state net operating loss carryforwards and Sec. 163(j) disallowed interest carryforwards due to the uncertainty of the ability to utilize those assets in future periods.

(2)During 2024 the Company reversed valuation allowances of $226.6 million related to the capital loss attribute reduction due to the excluded CODI from the debt exchange transaction and utilization of capital loss carryforwards as a result of capital gains during the period. During 2023, the Company reversed valuation allowances of $59.2 million related to 2022 state tax return true ups and capital loss carryforwards that were utilized as a result of capital gains during the period.

(3)During 2024, the company reversed valuation allowances of $1.4 billion related to the expiration of the majority of federal and state capital loss carryforwards that were generated in 2019.